Multibagger Selection: Grok 4.5's picks
Grok 4.5 picked INOD, PGY, TMDX, SEZL, CALX with a twelve-month thesis, measured against SPY at each checkpoint.
| Experiment | Multibagger Selection |
|---|---|
| Model | Grok 4.5 |
| Prompt version | multibagger-selection-v1 |
| Asked | |
| Horizon | 12-month |
| Benchmark | SPY |
| Status | Being measured |
The picks
| Rank | Symbol | Return | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|
| 1 | INOD | — | 72% | — | — |
| 2 | PGY | — | 68% | — | — |
| 3 | TMDX | — | 65% | — | — |
| 4 | SEZL | — | 63% | — | — |
| 5 | CALX | — | 58% | — | — |
Checkpoints
| Checkpoint | Portfolio return | Return vs SPY | Best peak multiple | Picks reaching 2x |
|---|---|---|---|---|
| 1 week | -2.75% | -2.46% | 1.11x | 0 |
The model's market view
Small- and mid-cap environment features resilient nominal growth supported by AI infrastructure and selective credit expansion, offset by higher-for-longer rates that pressure pure duration and low-quality balance sheets. Multibagger candidates concentrate in AI data services, specialty lending platforms, medical technology commercialization ramps, and high-engagement consumer finance where revenue acceleration, margin expansion, and near-term commercial or regulatory catalysts can produce asymmetric outcomes if execution holds.
Why each pick
INOD
Innodata supplies AI training, evaluation and data-engineering services to large technology customers. Revenue accelerated 58 percent year-over-year in Q2 2026 to $92.1 million with adjusted gross margin expanding to 49 percent; a new Big-Tech engagement already contributed material H1 revenue and reduced customer concentration. Positive free-cash-flow generation and a strong net-cash balance sheet support continued scaling.
PGY
Pagaya uses AI-driven underwriting to originate consumer credit that is then securitized. Revenue and net income have both expanded rapidly; the company has closed multiple large ABS transactions and continues to broaden its partner base. Profitability has inflected while the balance sheet remains manageable.
TMDX
TransMedics commercializes organ-care systems and logistics for heart, liver and lung transplants. Revenue continues to grow above 20 percent while the company advances a U.S. kidney program and European logistics expansion. The platform has already demonstrated clinical and commercial traction.
SEZL
Sezzle operates a high-engagement buy-now-pay-later and cash-advance platform with rapidly growing subscribers. Revenue and earnings have accelerated while free-cash-flow generation has strengthened; a pending national-bank-charter application could structurally improve unit economics.
CALX
Calix provides cloud and software platforms for broadband service providers, with an AI-native offering that is expanding. The company has been cited for deep discount relative to growth and is positioned for continued platform adoption as carriers invest in AI-enabled networks.
Other models on the same run
| Model | Picks |
|---|---|
| Claude Sonnet 5.5 | AMBQ, ASPN, SILC, ETON, CDNA |
| Muse Spark 1.1 | LUNR, PL, SOUN, BKSY, EXTR |
| Perplexity | RXRX, SOUN, ACHR, BBAI, CRSP |
| Gemini 3 Pro | ASTS, RKLB, SMR, LUNR, ACHR |
| DeepSeek | INOD, OUST, AEVA, LAES, AREC |
| GPT-6 | ARDX, AMPX, FLNC, TMDX, SERV |
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.